TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07108088: Evaluation of the NEUROSWING Orthosis on Walking Speed in a Population With Dorsal and/or Plantar Flexor Deficits, With a View to a Reimbursement Application. Clinical Investigation: NS-BOOSST

Sponsor: ÖSSUR France · Phase: PHASE2 · Area: RARE_ORPHAN · Target Enrollment: 34 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$16,480,000

Rescue Site Savings

+$10,866,500

Unlock Full NCT07108088 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07108088 Rescue Dossier →